12 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 23.0% per year over the past 5 years.
Operating margin has expanded, at -7.7% in the latest year.
Financial health
Total debt has grown slower than revenue (0.0% vs 23.0% per year).
Operating income covered interest expense -4.4× in the latest year.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$747M
-$45M
70.6%
-7.7%
$35M
—
$236M
2024
$592M
-$113M
68.9%
-19.5%
-$31M
—
$420M
2023
$493M
-$123M
67.3%
-25.4%
-$91M
$35M
$36M
2022
$411M
-$116M
68.5%
-27.7%
-$53M
$35M
$79M
2021
$323M
-$101M
66.2%
-31.0%
-$66M
$21M
$128M
2020
$265M
-$44M
73.5%
-16.5%
-$27M
$33M
$89M
2019
$215M
-$55M
75.5%
-25.5%
-$42M
$35M
$20M
2018
$147M
-$50M
73.7%
-31.0%
-$34M
$35M
$20M
2017
$99M
-$30M
71.5%
-27.8%
-$18M
$45M
$9M
2016
$64M
-$21M
67.4%
-24.3%
-$19M
$46M
$52M
2015
—
-$23M
—
—
—
$31M
$25M
2014
—
-$16M
—
—
—
—
$9M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$199M
-$14M
70.9%
-8.1%
-$33M
—
$240M
Dec '25
$209M
$6M
70.9%
1.1%
$14M
—
$236M
Sep '25
$193M
-$5M
71.1%
-4.4%
$20M
—
$256M
Jun '25
$187M
-$14M
71.2%
-10.0%
$17M
—
$309M
Mar '25
$159M
-$31M
68.8%
-20.5%
-$17M
—
$375M
Dec '24
$164M
-$1M
70.0%
-2.5%
$12M
—
$420M
Sep '24
$148M
-$46M
68.8%
-34.1%
$16M
—
$520M
Jun '24
$148M
-$20M
69.9%
-15.5%
$3M
—
$551M
Mar '24
$132M
-$46M
66.3%
-28.9%
-$62M
—
$520M
Dec '23
$133M
-$39M
66.0%
-29.6%
-$29M
$35M
$36M
Sep '23
$125M
-$27M
66.2%
-22.2%
-$8M
$35M
$47M
Jun '23
$124M
-$18M
69.5%
-15.2%
-$14M
$35M
$62M
Mar '23
$111M
-$39M
67.9%
-35.4%
-$39M
$35M
$53M
Dec '22
$113M
-$20M
69.9%
-18.4%
$5M
$35M
$79M
Sep '22
$104M
-$21M
68.3%
-20.3%
-$3M
$35M
$71M
Jun '22
$102M
-$24M
68.8%
-23.0%
-$11M
$35M
$101M
Mar '22
$92M
-$51M
66.9%
-52.6%
-$44M
$35M
$95M
Dec '21
$82M
-$32M
62.7%
-39.4%
-$18M
$21M
$128M
Sep '21
$85M
-$24M
65.7%
-27.3%
$4M
$13M
$167M
Jun '21
$81M
-$17M
68.0%
-20.9%
-$6M
$16M
$139M
Valuation over time
How the market has priced IRTC against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 9.9× (Mar '23) to 5.1× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is IRTC growing its revenue and profit?
Over the past 5 years, Irhythm Holdings, Inc.'s revenue has grown 23.0% per year. These are computed facts, not advice.
How much debt does IRTC have?
As of FY2025, Irhythm Holdings, Inc. reported — of total debt against $236M of cash; operating income covered interest expense -4.4×.
What is IRTC's profit margin?
In FY2025, gross margin was 70.6%, operating margin -7.7%, and net margin -6.0%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.